16
2014
Racial disparities in squamous cell carcinoma of the oral tongue among women: a SEER data analysis.

Lindsay J Joseph , Michael Goodman , Kristin Higgins , Rathi Pilai
Oral Oncology 51 ( 6) 586 -592

37
2015
Bcl2 inhibits recruitment of Mre11 complex to DNA double-strand breaks in response to high-linear energy transfer radiation.

Maohua Xie , Dongkyoo Park , Shuo You , Rui Li
Nucleic Acids Research 43 ( 2) 960 -972

16
2015
Oncogenic Ras and B-Raf Proteins Positively Regulate Death Receptor 5 Expression through Co-activation of ERK and JNK Signaling*

You-Take Oh , Ping Yue , Wei Zhou , Justin M. Balko
Journal of Biological Chemistry 287 ( 1) 257 -267

30
2012
CHFR protein expression predicts outcomes to taxane-based first line therapy in metastatic NSCLC

Rathi N. Pillai , Seth A. Brodie , Gabriel L. Sica , You Shaojin
Clinical Cancer Research 19 ( 6) 1603 -1611

16
2013
Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy

Viraj A. Master , Bassel El-Rayes , Suresh S. Ramalingam , Taofeek K. Owonikoko
BMC Cancer 19 ( 1) 857 -857

31
2019
EGFR fusions as novel therapeutic targets in lung cancer

Kartik Konduri , Jean-Nicolas Gallant , Young Kwang Chae , Francis J. Giles
Cancer Discovery 6 ( 6) 601 -611

52
2016
PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma

Michael R. Migden , Danny Rischin , Chrysalyne D. Schmults , Alexander Guminski
The New England Journal of Medicine 379 ( 4) 341 -351

1,011
2018
Efficacy of Selpercatinib in RET-Altered Thyroid Cancers

Benjamin Solomon , Hyunseok Kang , Jochen Lorch , Francis Worden
The New England Journal of Medicine 383 ( 9) 825 -835

46
2020
Overcoming acquired resistance of EGFR-mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib, with the natural product honokiol.

Hongjing Zang , Guoqing Qian , Jack Arbiser , Taofeek K. Owonikoko
Molecular Oncology 14 ( 4) 882 -895

19
2020
Biomarkers and targeted systemic therapies in advanced non-small cell lung cancer.

Mukesh Kumar , Vinicius Ernani , Taofeek K. Owonikoko
Molecular Aspects of Medicine 45 55 -66

20
2015
Maintenance Therapy for Advanced Non-small Cell Lung Cancer: Current Status, Controversies, and Emerging Consensus

Taofeek K. Owonikoko , Suresh S. Ramalingam , Chandra P. Belani
Clinical Cancer Research 16 ( 9) 2496 -2504

27
2010
Lung Cancer in Elderly Patients: An Analysis of the Surveillance, Epidemiology, and End Results Database

Taofeek K. Owonikoko , Camille C. Ragin , Chandra P. Belani , Ana B. Oton
Journal of Clinical Oncology 25 ( 35) 5570 -5577

631
2007
Effects of Rovalpituzumab Tesirine on Ventricular Repolarization in Patients With Small-Cell Lung Cancer

Jonathan W. Goldman , Minal Barve , Jyoti D. Patel , Antoinette Wozniak
Clinical and Translational Science 14 ( 2) 664 -670

2021
Modulation of Bax and mTOR for Cancer Therapeutics

Rui Li , Chunyong Ding , Jun Zhang , Maohua Xie
Cancer Research 77 ( 11) 3001 -3012

26
2017
Mcl-1 Interacts with Akt to Promote Lung Cancer Progression.

Guo Chen , Dongkyoo Park , Andrew T. Magis , Madhusmita Behera
Cancer Research 79 ( 24) 6126 -6138

5
2019
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1-targeted therapy in lung cancer patients.

Alice O Kamphorst , Rathi N Pillai , Shu Yang , Tahseen H Nasti
Proceedings of the National Academy of Sciences of the United States of America 114 ( 19) 4993 -4998

292
2017
Inositol-triphosphate 3-kinase B confers cisplatin resistance by regulating NOX4-dependent redox balance

Chaoyun Pan , Lingtao Jin , Xu Wang , Yuancheng Li
Journal of Clinical Investigation 129 ( 6) 2431 -2445

8
2019
Hsp90B enhances MAST1-mediated cisplatin resistance by protecting MAST1 from proteosomal degradation.

Chaoyun Pan , Jaemoo Chun , Dan Li , Austin C Boese
Journal of Clinical Investigation 129 ( 10) 4110 -4123

4
2019